Edge of wound Non-advancing
Using the T.I.M.E. clinical decision support tool (CDST) to guide clinical decision-making, aim to facilitate advancement of the wound edge
Measuring progression
Once tissue viability, infection and moisture have been addressed, wound epithelial edge advancement should indicate healing progression and treatment success.1,2
To help promote epithelialisation and healthy peri-wound skin, select appropriate solutions that may help to address abnormal or non-advancing wound edges.
Assess the wound to identify the right treatment or intervention
Related Products
Disclaimer
The products used in the T.I.M.E. clinical decision support tool may vary in different markets. Not all products referred to may be approved for use or available in all markets. Please consult your local Smith & Nephew representative for further details on products available in your market.
Intended for healthcare professionals outside of the US only.
A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Smith & Nephew does not dispense medical advice and recommends that healthcare professionals be trained in the use of any particular product before using it on patients.
For detailed product information, including indications for use, contraindications, effects, precautions, warnings, and important safety information, please consult the Instructions for Use (IFU) prior to use.
Citations
- Leaper DJ, et al. Int Wound J. 2012; 9 (Suppl 2):1-19.
- Pudner R. Dermatological Nursing; 2015; 14, 2, pp. 32-36.